The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis
- 1 September 1997
- journal article
- Published by SAGE Publications in Lupus
- Vol. 6 (7) , 559-560
- https://doi.org/10.1177/096120339700600701
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The mosaic of autoimmunityPublished by Elsevier ,2003
- Monoclonal anticardiolipin autoantibodies established from the (new zealand white x bxsb)f1 mouse model of antiphospholipid syndrome cross‐react with oxidized low‐density lipoproteinArthritis & Rheumatism, 1995
- Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cellsLupus, 1995
- Is atherosclerosis an immunologically mediated disease?Immunology Today, 1995
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- The antiphospholipid syndrome: ten years onThe Lancet, 1993
- Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosusThe Lancet, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).Journal of Clinical Investigation, 1992
- Outcome in Systemic Lupus ErythematosusMedicine, 1989